Nasus Pharma Ltd.
NSRXNYSEAMERICANHealthcareDrug Manufacturers - General
As of Oct 15, 2026 close
- Market cap
- $35.04M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.98$9.50
- Volume (live)
- -
- Avg. volume (3M)
- 18.78K
Nasus Pharma (NSRX) Stock Price & Financial Analysis
Nasus Pharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.09 - $3.24 |
|---|---|
| 52-Week High | $9.50 |
| 52-Week Low | $1.98 |
| Open | $3.09 |
| Volume (last close) | 15.04K |
| Average Volume (3M) | 18.78K |
| 50-Day MA | $3.64 |
|---|---|
| 200-Day MA | $3.90 |
| 1-Year Change | −60.04% |
| Market Cap | 35.04M |
|---|---|
| Shares Outstanding | 11.07M |
| Price to Book (P/B) | 3.19 |
| EV/EBITDA | -3.80 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Nasus Pharma at a Glance
As of the Oct 16, 2026 close, Nasus Pharma (NSRX) has a market capitalization of $35.04M.
As of its latest reported balance sheet, it holds $7.82M in cash and securities against $73.00K of debt, a net cash position of $7.75M.
Nasus Pharma does not currently pay a dividend.
The share price is down 60.0% over the past year. At $3.18 (the Oct 16, 2026 close) it sits within its 52-week range of $1.98 to $9.50, below its 200-day moving average of $3.90.
Frequently Asked Questions About Nasus Pharma
What is the current stock price for NSRX?
As of the Oct 16, 2026 close, NSRX stock trades at $3.18. The 52-week range is $1.98–$9.50, with a day range of $3.09–$3.24.
What is the P/E ratio for NSRX?
The P/E ratio (Price-to-Earnings) for NSRX is shown in the Key Statistics section. This valuation metric helps compare Nasus Pharma Ltd. to industry peers.
Does NSRX pay dividends?
Nasus Pharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NSRX?
Analyst ratings and recommendations for NSRX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NSRX?
As of the Oct 16, 2026 close, Nasus Pharma's market capitalization is $35.2M, classifying it as a micro-cap company. Nasus Pharma operates in the Healthcare sector within the Drug Manufacturers - General industry.